A Single Centre, Pilot Trial of YF476 in Patients With Chronic Atrophic Gastritis, Hypergastrinaemia and Type I Gastric Carcinoids.

Trial Profile

A Single Centre, Pilot Trial of YF476 in Patients With Chronic Atrophic Gastritis, Hypergastrinaemia and Type I Gastric Carcinoids.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Oct 2017

At a glance

  • Drugs Netazepide (Primary)
  • Indications Gastric atrophy; Gastric cancer
  • Focus Therapeutic Use
  • Sponsors Trio Medicines
  • Most Recent Events

    • 17 Oct 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.
    • 17 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top